Cellectis S.A. current report, Q2 FY2015

Cellectis S.A. Form 6-K Summary

Business Context and Reporting Period

This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, on June 2, 2015. The filing serves as a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934. The document primarily acts as a cover for a press release dated June 2, 2015, included as Exhibit 99.1.

Financial Metrics

The provided filing text does not contain specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity within this document. The filing text does not provide a clear value for any financial metric.

Material Changes

No material changes versus a prior comparable period are detailed in the provided text. The document serves as a vehicle for a press release but does not include the content of that release or comparative financial analysis.

Guidance, Outlook, and Risks

The filing text does not include management commentary, forward-looking guidance, risk factors, contingencies, or descriptions of unusual items. These details would be contained within the referenced press release (Exhibit 99.1), which is not included in the input text.

Key Facts for Investor Verification

  • The filing is a procedural Form 6-K referencing a press release dated June 2, 2015.
  • No financial statements or numerical data are present in this specific document text.
  • Investors must review the attached press release (Exhibit 99.1) to understand the specific corporate event or announcement triggering this filing.
  • The registrant files annual reports under Form 20-F.